AI assistant
Sending…
AXCELIS TECHNOLOGIES INC — Director's Dealing 2015
Feb 19, 2015
31374_dirs_2015-02-19_41258f65-d473-412f-8608-53dec7fbd9aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AXCELIS TECHNOLOGIES INC (ACLS)
CIK: 0001113232
Period of Report: 2015-02-17
Reporting Person: Bintz William J (EVP, Engineering and Marketing)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-17 | Common Stock | M | 10000 | $0.70 | Acquired | 84719 | Direct |
| 2015-02-17 | Common Stock | M | 47168 | $0.93 | Acquired | 131887 | Direct |
| 2015-02-17 | Common Stock | S | 54768 | $2.77 | Disposed | 77119 | Direct |
| 2015-02-17 | Common Stock | S | 2400 | $2.78 | Disposed | 74719 | Direct |
| 2015-02-18 | Common Stock | M | 27832 | $0.93 | Acquired | 102551 | Direct |
| 2015-02-18 | Common Stock | S | 27832 | $2.77 | Disposed | 74719 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-17 | Stock Option (right to buy) | $0.70 | M | 10000 | Disposed | 2018-11-17 | Common Stock (10000) | Direct |
| 2015-02-17 | Stock Option (right to buy) | $0.93 | M | 47168 | Disposed | 2019-07-16 | Common Stock (47168) | Direct |
| 2015-02-18 | Stock Option (right to buy) | $0.93 | M | 27832 | Disposed | 2019-07-16 | Common Stock (27832) | Direct |
Footnotes
F1: These options are from an original grant of 150,000 shares, of which 50% was vested on 7/16/2014, and 25% will vest on each of 7/16/2015 and 7/16/2016.
F2: See footnote 1.
More from AXCELIS TECHNOLOGIES INC
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 6
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3